Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

IDEXX LABORATORIES INC /DE Director's Dealing 2015

Feb 18, 2015

30016_dirs_2015-02-18_1e47efa2-fd19-45ce-a013-754ccb32805f.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: IDEXX LABORATORIES INC /DE (IDXX)
CIK: 0000874716
Period of Report: 2015-02-14

Reporting Person: POWERS JOHNNY D (Executive Vice President)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2015-02-14 Common Stock M 202 Acquired 10202 Direct
2015-02-14 Common Stock M 273 Acquired 10475 Direct
2015-02-14 Common Stock M 257 Acquired 10732 Direct
2015-02-14 Common Stock M 241 Acquired 10973 Direct
2015-02-14 Common Stock M 375 Acquired 11348 Direct
2015-02-14 Common Stock F 453 $159.08 Disposed 10895 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2015-02-14 Non-Qualified Stock Option (right to buy) $159.08 A 13424 Acquired 2025-02-13 Common Stock (13424) Direct
2015-02-14 Incentive Stock Option (right to buy) $159.08 A 628 Acquired 2025-02-13 Common Stock (628) Direct
2015-02-14 Restricted Stock Unit $ A 1179 Acquired Common Stock (1179) Direct
2015-02-14 Restricted Stock Unit $ M 202 Disposed Common Stock (202) Direct
2015-02-14 Restricted Stock Unit $ M 273 Disposed Common Stock (273) Direct
2015-02-14 Restricted Stock Unit $ M 257 Disposed Common Stock (257) Direct
2015-02-14 Restricted Stock Unit $ M 241 Disposed Common Stock (241) Direct
2015-02-14 Restricted Stock Unit $ M 375 Disposed Common Stock (375) Direct

Footnotes

F1: Grant of option to buy shares of IDEXX Laboratories, Inc. common stock that becomes exercisable as to 2,811 shares on 02/14/2016 and 02/14/2017, 2,810 shares on 02/14/2018 and 02/14/2019, and the remaining 2,182 shares on 02/14/2020.

F2: Grant of option to buy shares of IDEXX Laboratories, Inc. common stock that vests on the fifth anniversary date (02/14/2020) of the grant.

F3: Each restricted stock unit represents a contingent right to receive one share of IDEXX Laboratories, Inc. common stock. The restricted stock units vest in five equal annual installments, beginning on the first anniversary date (02/14/2016) of the date of grant.

F4: Each restricted stock unit represents a contingent right to receive one share of IDEXX Laboratories, Inc. common stock. The restricted stock units vested in five equal annual installments, beginning on the first anniversary date (02/14/2015) of the date of grant.

F5: Each restricted stock unit represents a contingent right to receive one share of IDEXX Laboratories, Inc. common stock. The restricted stock units vested in five equal annual installments, beginning on the first anniversary date (02/14/2014) of the date of grant.

F6: Each restricted stock unit represents a contingent right to receive one share of IDEXX Laboratories, Inc. common stock. The restricted stock units vested in five equal annual installments, beginning on the first anniversary date (02/14/2013) of the date of grant.

F7: Each restricted stock unit represents a contingent right to receive one share of IDEXX Laboratories, Inc. common stock. The restricted stock units vested in five equal annual installments, beginning on the first anniversary date (02/14/2012) of the date of grant.

F8: Each restricted stock unit represents a contingent right to receive one share of IDEXX Laboratories, Inc. common stock. The restricted stock units vested in five equal annual installments, beginning on the first anniversary date (02/14/2011) of the date of grant.